1.13 KEYNOTE-189, Dr. Talal Hilal on MRD, and Medical Education with Dr. Adam Cifu

OncologyMedicineHealth Policy
Written By Kerrington .

Listen in for a breakdown of the good and the bad of KEYNOTE-189 (trial published in NEJM), a discussion with Dr. Talal Hilal of the Mayo Clinic on the rise of minimal residual disease as a clinical endpoint, and an interview with Dr. Adam Cifu of the University of Chicago Pritzker School of Medicine on medical education, sham trials, and more.

Kerrington .
Previous

1.15 Minimally Effective Treatments, CheckMate 331, and Dr. Adam Obley on Low-Value Healthcare
Next

1.12 BONUS! Evidence-Based Medicine Has Been Hijacked in Oncology